Cancer Patients Give Blood Cells to Advance Treatment Studies
Cancer patients are fighting back and helping advance the development of cutting edge cancer treatments by giving blood cells for laboratory medical research. Patients giving small amounts of white blood cells allow preclinical scientists to study the potential effectiveness and critical safety of innovative immune treatments.
Why are Patients’ Blood Cells Needed?
Immune therapies sometimes called cancer “vaccines,” program a patient’s immune system with powerfully altered white blood cells that specifically target their kind of malignancy. Careful laboratory tests using donors’ blood immune cells must come before promising cancer treatments can be cleared for clinical use in patients.
While healthy individuals’ donated blood cells also importantly help fuel research, treatments for specific cancers can be more effectively investigated using white blood cells samples from patients with those specific diagnoses.
Initial immune-oncologic therapies being used in clinical trials in the U.S. for several cancers types are providing encouraging results. To improve those treatments and identify new ones for other conditions and for larger groups of patients, laboratory scientists must learn if different types of individuals’ cells respond differently.
Are Key Biologics’ (A Cellero Company) Patient Blood Cell Donors Getting Experimental Treatments?
No. Key Biologics patient blood donors do not receive any experimental treatment. Their blood cells also are not administered as treatments to anyone else. These Research Champion patients’ blood cells help drive the lab studies that could improve countless lives in the future and possibly help identify cures.
What Specific Types of Cancer Treatments are Patient Donors Helping Advance?
Currently, patients with 4 types of blood cancer are needed for studies into treatments for their diagnoses: Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma, Multiple Myeloma, and Acute Lymphocytic Leukemia. Patients with Acute Myeloid Leukemia also will be needed in 2019.
Patients with solid tumor cancers can join the fight by also giving blood cells for research at Key Biologics later in 2019.
Who is Eligible to Fight Back as a Patient Blood Cell Donor?
Men and women, ages 18-65, who meet research requirements, to ensure their safe participation. These patients also provide important personal feedback to help improve IV blood cells collection procedures that increasingly will be a part of cutting edge immune therapy patient care.
Questions? Contact us at 833-CELLERO.